AlphAIAlphAI — Financial news for AI agents
finance.yahoo.com$CAH

Cardinal Health Inc (CAH) (Q1 2027) Earnings Call Highlights: Record $1 Billion

Cardinal Health (CAH) reported Q1 2027 earnings with record operating income of $1 billion. GMPD segment revenue was flat at $3.2B, with full-year profit expected toward the low end of $200-$220M due to high petroleum costs. Pharmaceutical revenue growth faced headwinds from IRA WAC reductions, partially offset by GLP-1 growth. Earnings growth is expected to moderate in Q2 and Q3 before strengthening in Q4. The company raised its fiscal 2027 EPS guidance to $12.80-$13.00, up from $12.40-$12.60.

Original reporting
finance.yahoo.com
Published Nov 5, 2026, 11:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 11:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Cardinal Health Inc (CAH) (Q1 2027) Earnings Call Highlights: Record $1 Billion — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$CAHBullishHigh
01

Why it matters

The raised EPS guidance and $500 M buyback signal strong cash generation, likely prompting a price rally.

02

Market read

First‑time disclosure of FY2027 EPS guidance and sizable share repurchase for a large‑cap health distributor, creating immediate trading relevance.

03

What to watch

Potential regulatory changes to 340B reimbursement and foreign‑exchange headwinds could dampen the upside.

Relevance 8/10Novelty 9/10Timing: after‑hours release

Background

Cardinal Health provided its Q1 2027 earnings call highlights, including segment performance, cost pressures, and updated guidance.

Company-level read

Ticker impact

$CAHBullishHigh confidence
Context

Cardinal Health raised FY2027 non‑GAAP EPS guidance to $12.80‑$13 and announced a $500 M share repurchase in Q1, plus $5.3 B cash balance.

Expected impact

likely upward pressure as investors price in higher earnings and strong cash flow

Evidence & confidence

The new EPS range and sizable buyback tranche are material, first‑time disclosed numbers for a large‑cap health distributor.

Market effects

Sector

Positive for pharmaceutical distribution and medical supply peers as higher guidance may lift sector sentiment.

Regional

U.S. health‑care stocks could see modest gains in early trade.

Global

Limited to U.S. markets; no direct global ripple.

Counterpoint

What could challenge this read

If the guidance assumes continued high petroleum costs, any further escalation could pressure margins and reverse the upside.

Key entities

  • Company
    Cardinal Health Inc

    U.S. health‑care services and distribution company.

  • Executive
    Jason Hollar

    CEO of Cardinal Health, provided commentary on segment performance.

  • Executive
    Aaron Alt

    CFO of Cardinal Health, disclosed financial metrics and guidance.

Read at source← All news

StoryCardinal Health posts strong Q1 results and lifts FY2027 non‑GAAP EPS outlook

Also covered by

5 outlets

Related articles

$CAHHighAI 8/10

Cardinal Health Q1 Earnings Call Highlights

Cardinal Health (CAH) raised its full-year pharmaceutical segment profit growth forecast to 10-12% and maintained revenue growth outlook of 3-5%. CEO Jason Hollar highlighted contract renewals, including a long-term agreement with CVS Health. Medical unit revenue was flat at $3.2B, but profit exceeded expectations. The company raised its annual revenue and profit growth forecasts for its 'other' category, citing strong demand.

finance.yahoo.com
$CAHHighAI 8/10

Cardinal Health Raises Fiscal 2027 Growth Targets for Two Segments

Cardinal Health raised its fiscal 2027 earnings forecast after Q1 non-GAAP EPS rose 28% to $3.26. Revenue increased 5% to $67.513 billion. Pharmaceutical and Specialty Solutions revenue grew 6%, while Global Medical Products and Distribution revenue was flat. The company also completed $500 million in share repurchases.

tokenpost.com
$CAHHighAI 8/10

Cardinal Health (CAH) Q1 2027 Earnings Call Transcript

Cardinal Health (CAH) reported Q1 2027 revenue of $67.5B (+5% YoY) and raised fiscal 2027 EPS guidance to $12.80-$13.00. The company renewed its contract with CVS Health (CVS) through 2032, securing long-term stability. Pharma segment revenue grew 6%, while GMPD revenue was flat. Profit increased across all segments, with operating income reaching $1B. The company repurchased $500M in shares and maintained strong cash flow.

finance.yahoo.com
$CAHHighAI 8/10

We're raising our price target on Cardinal Health after another stellar quarter of profits

Cardinal Health (CAH) reported Q1 FY2027 revenue of $67.51B (+4% YoY) and adjusted EPS of $3.26 (+28% YoY), beating estimates. The company raised its full-year EPS guidance to $12.80-$13.00. Shares rose over 3% on the news. CEO Jason Hollar highlighted strong demand in the Pharmaceutical and Specialty Solutions segment. The company also repurchased $500M in stock. Analysts raised the price target to $300 from $265.

cnbc.com